UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057006
Receipt number R000065018
Scientific Title Estimation of Skeletal Muscle Mass Using Digital Images and Machine Learning
Date of disclosure of the study information 2025/02/14
Last modified on 2025/02/12 20:10:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Estimation of Skeletal Muscle Mass Using Digital Images and Machine Learning

Acronym

Estimation of Skeletal Muscle Mass Using Digital Images

Scientific Title

Estimation of Skeletal Muscle Mass Using Digital Images and Machine Learning

Scientific Title:Acronym

Estimation of Skeletal Muscle Mass Using Digital Images

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop and validate a method for estimating skeletal muscle mass using machine learning algorithms applied to digital images of the lower leg in healthy adults.
Japan's aging rate is rapidly increasing, with predictions suggesting that by 2050, 37.1% of the total population will be 65 years or older. In this super-aged society, addressing malnutrition and sarcopenia has become a critical issue. The GLIM criteria for malnutrition diagnosis and the AWGS 2019 criteria for sarcopenia in Asians emphasize the importance of skeletal muscle mass assessment. Conventional methods for evaluating skeletal muscle mass (such as DXA, BIA, MRI, and CT) require expensive equipment and specialized skills, making them difficult to use in general medical facilities or home healthcare settings. On the other hand, simpler methods like measuring calf circumference have accuracy issues.
Recently, digital image classification using machine learning has gained attention as a highly accurate method for measuring skeletal muscle mass. This study will utilize lower leg images captured by smartphones or digital cameras to verify the predictive accuracy of skeletal muscle mass estimation using machine learning algorithms.
This research is a basic study targeting healthy adults and cannot be directly applied to sarcopenia diagnosis or skeletal muscle mass assessment in the elderly. However, the findings of this study are expected to provide fundamental insights into rapid and accurate methods for evaluating skeletal muscle mass, with potential future applications for a wide range of subjects, including hospitalized patients and community-dwelling elderly.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Digital image (single evaluation time point)

Key secondary outcomes

age, sex, height, weight, Body Mass Index, skeletal muscle mass, calf circumference, grip strength, lower leg length (single evaluation time point)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Measurement of body weight and skeletal muscle mass using InBody:
Body weight and skeletal muscle mass of the limbs will be measured in a standing position. The Skeletal Muscle mass Index (SMI) will be calculated by adjusting the skeletal muscle mass for height.

Digital image capture:
The lateral and posterior aspects of the non-dominant lower leg will be photographed against a white background floor and back panel. A digital camera (SONY Cyber-shot DSC-WX220) and a smartphone (Android, OPPO Reno5 A) will be used for capturing images. Care will be taken to ensure the non-measured leg does not appear in the frame. The distance between the lens and the lower leg will be kept constant, with the lens fixed on a tripod. A level attached to the tripod will be used to ensure horizontal alignment. To minimize hand shake, a timer will be used for the shutter release. Three images will be taken, and one will be selected after visual confirmation. The measurement position for the lateral aspect of the lower leg will be seated, while the posterior aspect will be captured in a standing position. The ankle dorsiflexion angle will be standardized at 0 degrees.

Measurement of calf circumference:
The maximum calf circumference of the non-dominant leg will be measured using a tape measure, with the subject either seated or standing.

Grip strength measurement:
Grip strength will be measured in a standing position using a digital dynamometer, alternating between left and right hands twice each. When gripping the dynamometer, the arm should hang naturally, ensuring the device does not touch the body or clothing.

Height measurement:
Height will be measured using a stadiometer with the subject standing barefoot.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Those who have provided written consent to participate in the research
(2) Individuals aged 18 years or older

Key exclusion criteria

(1) Those who have difficulty maintaining a standing position
(2) Those with edema or similar conditions in the lower leg
(3) Those with implanted medical devices such as cardiac pacemakers
(4) Those with any limb amputation
(5) Those with metal implants or bolts in their body
(6) Those who are pregnant or possibly pregnant
(7) Those with a history of fractures or ligament injuries in the lower limbs
(8) Those with a history of central or peripheral nervous system disorders
(9) Those deemed unsuitable as research subjects by the principal investigator and co-investigators

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroo
Middle name
Last name Matsuse

Organization

Kurume University Hospital

Division name

Department of Rehabilitation

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka 830-0011, Japan

TEL

0942-35-3311

Email

matsuse_hiroh@kurume-u.ac.jp


Public contact

Name of contact person

1st name Hiroo
Middle name
Last name Matsuse

Organization

Kurume University Hospital

Division name

Department of Rehabilitation

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka 830-0011, Japan

TEL

0942-35-3311

Homepage URL


Email

matsuse_hiroh@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center, Kurume University Hospital

Address

67 Asahi-machi, Kurume-shi, Fukuoka 830-0011, Japan

Tel

0942-65-3749

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

久留米大学病院、九州栄養福祉大学、小倉リハビリテーション病院、九州工業大学


Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 01 Month 30 Day

Date of IRB

2025 Year 01 Month 30 Day

Anticipated trial start date

2025 Year 02 Month 14 Day

Last follow-up date

2026 Year 08 Month 31 Day

Date of closure to data entry

2026 Year 09 Month 30 Day

Date trial data considered complete

2026 Year 10 Month 31 Day

Date analysis concluded

2026 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2025 Year 02 Month 12 Day

Last modified on

2025 Year 02 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065018